这是一篇来自已证抗体库的有关
人类 SF3B1的综述,是根据9篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合SF3B1 抗体。
SF3B1 同义词: Hsh155; MDS; PRP10; PRPF10; SAP155; SF3b155
艾博抗(上海)贸易有限公司
domestic rabbit 多克隆 | | 艾博抗(上海)贸易有限公司 SF3B1抗体(Abcam, ab66774)被用于被用于免疫细胞化学在小鼠样本上 和 被用于免疫印迹在小鼠样本上 (图 4). PLoS Genet (2017) ncbi |
domestic rabbit 单克隆(EPR11987(B)) | | 艾博抗(上海)贸易有限公司 SF3B1抗体(ABCAM, ab170854)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s1c). Oncogene (2017) ncbi |
domestic rabbit 单克隆(EPR11987(B)) | | 艾博抗(上海)贸易有限公司 SF3B1抗体(Abcam, ab170854)被用于被用于免疫印迹在人类样本上 (图 2d). Cell Rep (2016) ncbi |
赛默飞世尔
domestic rabbit 多克隆 | | 赛默飞世尔 SF3B1抗体(Thermo Scientific, PA5-19679)被用于. elife (2015) ncbi |
MBL International
单克隆 | | MBL International SF3B1抗体(MBL, D221-3)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 7d). Oncogenesis (2020) ncbi |
单克隆 | | MBL International SF3B1抗体(MBL, D221-3)被用于被用于免疫印迹在人类样本上 (图 e2d). Nature (2019) ncbi |
单克隆 | | MBL International SF3B1抗体(Medical & Biological Laboratories Co, D221-3)被用于被用于免疫印迹在人类样本上 (图 5a). Mol Cell (2019) ncbi |
单克隆 | | MBL International SF3B1抗体(MBL International, D221-3)被用于被用于免疫印迹在人类样本上浓度为1:250 (图 4j). PLoS Pathog (2015) ncbi |
单克隆 | - 免疫细胞化学; 人类; 图 4
- 免疫印迹; 人类; 图 4
| MBL International SF3B1抗体(MBL International, p221-3)被用于被用于免疫细胞化学在人类样本上 (图 4) 和 被用于免疫印迹在人类样本上 (图 4). Cancer Res (2015) ncbi |
Ailiken G, Kitamura K, Hoshino T, Satoh M, Tanaka N, Minamoto T,
et al. Post-transcriptional regulation of BRG1 by FIRΔexon2 in gastric cancer. Oncogenesis. 2020;9:26
pubmed 出版商
Inoue D, Chew G, Liu B, Michel B, Pangallo J, D Avino A,
et al. Spliceosomal disruption of the non-canonical BAF complex in cancer. Nature. 2019;574:432-436
pubmed 出版商
Lee S, Mayr C. Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. Mol Cell. 2019;:
pubmed 出版商
Soboleva T, Parker B, Nekrasov M, Hart Smith G, Tay Y, Tng W,
et al. A new link between transcriptional initiation and pre-mRNA splicing: The RNA binding histone variant H2A.B. PLoS Genet. 2017;13:e1006633
pubmed 出版商
Kesarwani A, Ramirez O, Gupta A, Yang X, Murthy T, Minella A,
et al. Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3' splice sites within RNA secondary structures. Oncogene. 2017;36:1123-1133
pubmed 出版商
Grohar P, Kim S, Rangel Rivera G, Sen N, Haddock S, Harlow M,
et al. Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma. Cell Rep. 2016;14:598-610
pubmed 出版商
Zhang L, Tran N, Su H, Wang R, Lu Y, Tang H,
et al. Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15 controls RNA splicing. elife. 2015;4:
pubmed 出版商
Schreiber C, Sakuma T, Izumiya Y, Holditch S, Hickey R, Bressin R,
et al. An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses. PLoS Pathog. 2015;11:e1005082
pubmed 出版商
Zhou Q, Derti A, Ruddy D, Rakiec D, Kao I, Lira M,
et al. A chemical genetics approach for the functional assessment of novel cancer genes. Cancer Res. 2015;75:1949-58
pubmed 出版商